Actively Recruiting
Characterization of Liver Problems in Turner Syndrome Observational Study of Causes and Liver Assessments
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-27
120
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to explore the frequency and causes of liver changes in adult women diagnosed with Turner Syndrome (TS). The study focuses on identifying biochemical and structural liver abnormalities and understanding the factors that may contribute to liver disease in this population. By investigating these aspects, the study hopes to provide important insights into the development and prognosis of liver problems in TS patients. The study is observational and retrospective, involving adult women with TS who are being monitored over time at the Endocrinology and Diabetes Prevention and Care unit of IRCCS Policlinico S. Orsola in Bologna. Diagnosis of TS was confirmed by karyotype analysis of peripheral blood, typically performed during childhood or adulthood at specialized centers. Participants undergo clinical evaluations including measurement of body parameters, and detailed medical history reviews focusing on metabolic and autoimmune conditions, menstrual cycle history, and hormone replacement therapies. Laboratory tests related to liver function are also conducted as part of the routine clinical assessment. Participants will be involved through ongoing monitoring of their clinical and laboratory data as part of standard care. Researchers will review medical histories and collect data on liver function and related factors to identify any associations with liver disease in TS. The primary outcome measure is factors associated with liver disease at baseline. The study aims to generate new hypotheses about liver disease development and progression in women with Turner Syndrome, contributing valuable etiologic and prognostic information.
CONDITIONS
Official Title
Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.
- Age 18 years or older
- Written informed consent obtained
You will not qualify if you...
- TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
A
Alessandra Gambineri, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here